View Exam | PowerPak

1. Which of the following statements about medication errors is false?

A. They impact an estimated 1.5 million people every year. B. They are not preventable. C. Costs of treating drug-related injuries is estimated at $77 billion annually. D. Economics costs are the only costs associated with medication errors.

2. Medication errors can occur throughout the medication process. Which of the following aspects of the medication use process has the most commonly documented error rates based on an analysis of pharmacist liability claims in 2018?dispensing errors include which of the following?

A. Dispensing the wrong drug B. Dispensing the wrong dose C. Failing to consult with the prescriber on a question or concern D. Giving the medication to the wrong patient

3. Which of the following outcomes associated with medication errors occurs most commonly based on the 2018 study of pharmacist liability claims?

A. Patient death B. Interventions to save a patient's life C. Temporary patient harm requiring intervention with prolonged hospitalization D. Temporary patient harm requiring intervention

4. All of the following issues related to the ISMP's Key Elements of the Medication Use Process can result in medication errors EXCEPT?

A. Failure to obtain patient's demographic and clinical information B. Carefully labeling shelves, separating dosage forms, flagging high-risk medication and using TALL man letters to ensure best practice in drug storage, stock, standardization and distribution. C. Poor lighting, noise, interruptions and other environmental factors. D. Failing to counsel patients on medications

5. E-Prescribing systems have been implemented widely since the Institute of Medicines 2001 report, “To Err is Human.” Which statement about e-prescribing systems is false?

A. They have been shown to decrease prescribing errors, increase efficiency and help save healthcare costs. B. They generated 80% of all prescriptions in 2019 and becoming required by many states. C. They allow clinical messages to be communicated between providers including managing prior authorizations electronically. D. They are so foolproof that the pharmacy team does not need to be concerned with reviewing medications, dose and directions during data entry.

6. There are a number of strategies than can be employed throughout the medication use process to reduce the likelihood of medication errors. Avoiding abbreviations is one action that can reduce medication errors. Which of the following abbreviations is acceptable to use according to the Joint Commission?

A. BID B. QOD C. MS D. QD

7. The ISMP and PSOs have developed risk assessment tools for organizations to use for all the following purposes except:

A. Assess medication use processes for potential improvements B. Identify safety risks before mistakes are made C. Allow pharmacy team discussion to create action plans to address findings D. Identify team member who make mistakes in order to take disciplinary action

8. All of the following are ISMP tools designed for the community/ambulatory care environment EXCEPT?

A. Medication Safety Self Assessment® for Community/Ambulatory Pharmacy B. Assessing Workflow Systems in Community Pharmacies C. Assess-ERR™ Medication System Worksheets D. Root Cause Analysis Workbook for Community/Ambulatory Pharmacy

9. When errors do occur, which of the following actions is most appropriate?

A. Putting the patient first and determining what is best for the patient in order to reduce harm. B. Setting aside error investigation for workup when the pharmacy is not busy. C. Explaining to the patient all the safety systems and double checks that the pharmacy uses to make any errors unlikely so their concerns may be unfounded D. Making excuses, getting defensive and dismissing patient concerns

10. Which statement is true about national medication error reporting programs?

A. They are required to be used when errors are discovered B. They are operated by the Secretary of Health and Human Services through the United States Pharmacopeia (USP) C. They are used to identify patterns in medication errors and analysis and reports can provide important early warning systems and strategies to prevent medication errors in the future D. They are operated by IMSP and the FDA